key: cord-0754525-ca04j8sc
authors: Dhanani, Lindsay Y.; Franz, Berkeley
title: A Meta-Analysis of COVID-19 Vaccine Attitudes and Demographic Characteristics in the United States
date: 2022-03-28
journal: Public Health
DOI: 10.1016/j.puhe.2022.03.012
sha: c89e06ed43a0afb01239c75ac65912144b919b3b
doc_id: 754525
cord_uid: ca04j8sc

Objectives Despite the potential for COVID-19 vaccination to prevent severe disease and death, vaccine hesitancy is common in the United States with more than a quarter of eligible Americans yet to receive a first dose. We draw on existing published studies on COVID-19 vaccine attitudes to estimate the overall prevalence of vaccine hesitancy and assess how it varies across demographic groups. Study Design A systematic literature search was conducted to identify and meta-analyze relevant studies which examined vaccine acceptance and hesitancy in the context of the COVID-19 vaccine. Methods We meta-analyzed the prevalence rate of vaccine acceptance across all participants as well as for specific demographic subgroups. To assess time effects, we coded each study for the month during which data were collected and subjected the meta-analytic data to a regression analysis. To assess the magnitude of differences between demographic subgroups, we conducted a separate meta-analysis of odds ratios. Results Across the 46 samples, an average of 61% of participants indicated they were willing to receive the COVID-19 vaccine. The biggest demographic differences were found for race and political affiliation, with Black respondents and Republicans reporting significantly higher vaccine hesitancy than White respondents and Democrats. Conclusions These results inform current vaccination efforts by identifying the groups that are least likely to get vaccinated and supporting the need for tailored vaccine strategies to alleviate the concerns specific to those populations. Comparing intentions to vaccinate with actual vaccination rates, vaccine hesitancy appears to have declined considerably among women and Black Americans.

vaccination rates, vaccine hesitancy appears to have declined considerably among women and Black Americans.

Despite widespread availability, more than a quarter of eligible Americans have yet to receive a first dose of a COVID-19 vaccine. 1 Given the potential for vaccines to reduce disease severity and transmission, it is critical to understand how to improve vaccine uptake. Vaccine hesitancy, however, is not shared equally among different demographic groups in the U.S. and Americans may remain unvaccinated for different reasons, requiring different intervention strategies. The goal of the paper is to meta-analytically examine the prevalence of vaccine acceptance both generally and within specific subgroups to determine what proportion of people remain vaccine hesitant and how that varies as a function of demographic group membership.

Vaccine hesitancy, defined by the World Health Organization as "a delay in acceptance or refusal of vaccines despite availability of vaccination services," exists across social groups in the United States. 2 In the context of COVID-19, early studies have uncovered specific groups at risk of vaccine hesitancy, although no studies have systematically compared COVID-19 vaccine hesitancy across social or demographic groups. This preliminary evidence demonstrates that vaccine hesitancy intersects with vulnerability to COVID-19 and has important implications for reducing the burden of COVID-19 disease in the United States. For example, older adults are the least likely to report vaccine hesitancy and have received vaccinations at rates higher than any other age group. Conversely, long-term care residents and staff are among the most susceptible to infectious diseases such as COVID- 19 . 4 Yet, states reporting data on long-term care staff have indicated that between 30-50% of staff accepted the COVID-19 vaccine when it was first offered. 5 J o u r n a l P r e -p r o o f Racial/ethnic disparities in vaccine uptake are also apparent with lower vaccination rates observed among Black and Hispanic Americans, despite racial/ethnic minorities being at elevated risk for COVID-19-related mortality. This could reflect vaccine hesitancy or barriers in accessing vaccines. 6, 7 Similarly, low-income, rural adults, and those residing in socially vulnerable communities have been less likely to receive a COVID-19 vaccination, mirroring previous research on H1N1 vaccination. 8 Research indicates that specific social groups remain unvaccinated and vulnerable to severe COVID-19 disease. 9, 10 No studies, however, have compared the prevalence of vaccine hesitancy across different groups and time. The goal of this analysis is to draw on existing published studies on COVID-19 vaccine attitudes to identify how vaccine acceptance rates vary across demographic groups. This meta-analysis will be the first to comprehensively assess the demographic characteristics associated with COVID-19 vaccine acceptance which has important implications for developing successful, targeted vaccine uptake interventions.

A systematic literature search was conducted in August 2021 to identify relevant studies which have examined vaccine acceptance and hesitancy in the context of the COVID-19 vaccine (this review was not registered). Given that such studies could be published in a broad array of journals (e.g., medical journals, social science journals), we conducted the search using a general search platform (i.e., ArticlesPlus) which simultaneously draws from all databases. That is, this search feature does not require authors to select a predetermined set of databases and instead searches in all databases simultaneously. We paired the following COVID-19 related search terms, COVID-19 or Sars-Cov-2 or coronavirus, with search terms related to vaccine acceptance J o u r n a l P r e -p r o o f (i.e., vaccine acceptance or vaccine compliance or vaccine hesitancy or vaccine resistance or vaccine uptake or vaccine intention or vaccine willingness). We also included jabs in our search terms to capture studies that used alternative labels for vaccines. Additional studies were located by searching Google Scholar and examining the reference lists of the studies produced through the systematic literature search.

Studies were eligible for inclusion if they measured participants' willingness to receive or decline the COVID-19 vaccine; were conducted in the United States; and reported a sample size and the number of participants who reported they would accept and/or decline the vaccine.

Studies were excluded if they assessed vaccine acceptance after experimentally manipulating messaging about the vaccine and/or characteristics about the vaccine as these estimates do not reflect people's general vaccine acceptance. Both published and unpublished studies were eligible for inclusion. The search procedures described above yielded a total of 2,083 search hits.

Screening was completed by the first author and Figure 1 displays the number of studies that were excluded in the screening process and the reasons for exclusion. The screening process produced a total of 44 studies with 46 independent samples (N = 167,833) that were eligible for inclusion in our analyses.

Studies were coded for the total number of participants as well as the number of participants who reported they would accept and/or decline the COVID-19 vaccination. Where available, data were also recorded for demographic subgroups within the sample, including: sex, race/ethnicity, age, income, education, location, and political affiliation. Sex was categorized as male and female and race/ethnicity included White, Black, and Hispanic participants. For age, we examined the youngest age group, which typically ranged from 18-29 in primary studies, as J o u r n a l P r e -p r o o f well as the oldest age group, which typically included participants who were 60 years of age or older. Participant education included two categories which reflected having educational attainment which fell below earning a bachelor's degree or having earned a bachelor's, professional, or graduate degree. Income was coded as either earning below $60,000 or above $60,000 and this cutoff point was used because it roughly corresponds to the median income in the United States. Location was coded as rural or urban/suburban. Political affiliation included identifying with the two major parties in the United States (i.e., Democrat and Republican). The date of data collection was also recorded and studies were classified as occurring before and after the COVID-19 vaccine was approved for emergency use. Finally, studies were coded for sampling technique and studies were categorized as probability samples if participants had an equal and known probability of being in the sample. This information was used to assess the possible risk of bias in individual studies given that nonprobability sampling is more likely to produce nonrepresentative samples. The coded information for each included study is available in Table 1 in supplemental materials.

Each study included in the meta-analysis was independently coded by both study authors.

Initial agreement across all coded information was 99% and any disagreements were discussed until consensus was reached.

The coded data were included in two separate meta-analyses. First, we meta-analyzed the prevalence rate of vaccine acceptance across all participants as well as for specific demographic subgroups. Prevalence rates for each primary study were calculated as the total number of participants who reported they would accept the vaccine divided by the total number of participants. We calculated the average prevalence rate across studies using the Metafor package J o u r n a l P r e -p r o o f in R and analyses were conducted using random effects meta-analytic procedures. We also constructed a forest plot and assessed publication bias for the global prevalence rate estimate using the Metafor package. To assess vaccine attitudes over time, we coded studies for the month of data collection (primary studies ranged from March 2020 to May 2021) and subjected the meta-analytic data to a regression analysis wherein the effect size was the dependent variable and date of data collection was the predictor. 11 To assess the differences between demographic subgroups, we conducted a separate meta-analysis of odds ratios in which we examined the relative odds of vaccine refusal in each related subgroup (e.g., we conducted an odds ratio to compare men and women). To calculate the odds ratios, we recorded the number of participants in each demographic subgroup who indicated they would refuse and accept the vaccine. We used the Metafor package in R and a random effects model to conduct our meta-analysis of odds ratios, and we present the meta-analytic findings for both the untransformed odds ratios as well as the log transformed odds ratios (presented in Table 2 only). Odds ratios greater than 1.00 indicate that the group noted in column 1 of Table 2 is more likely to decline the vaccine than their referent group.

We assessed the overall quality of our meta-analytic review using the AMSTAR assessment. 12 Our meta-analysis met all criteria provided in the assessment with one exception, which is that the studies produced by the systematic search were only screened by a single person.

Results for the general population suggested that, across the 46 included samples, an average of 61% (95% CI [.56, .66]) of participants indicated they were willing to receive the J o u r n a l P r e -p r o o f COVID-19 vaccine (Table 1) . A forest plot of the effect sizes for each study plotted against the sample size is shown in Figure 2 . The studies were also assessed for publication bias and the funnel plot is shown in Figure 3 . A test of the asymmetry in the funnel plot was not significant (z = -1.25, p = .212), indicating no evidence of publication bias. There was one study with a particularly large sample size (N = 73,650) and a similar prevalence rate was found when that study was removed (p ̅= .61, 95% CI [.55, .66]). Finally, though the prevalence rate was higher in studies that used probability rather than nonprobability samples, this difference was not significant.

We separately examined studies that assessed vaccine acceptance among healthcare professionals given their importance in influencing the decisions of, and their high contact with, patients. Results indicated that roughly half of healthcare personnel were willing to receive the vaccine (p ̅ = .55, k = 9, 95% CI [.45, .65]), which suggests that vaccine acceptance among healthcare professionals may lag behind that seen for other groups. Prevalence rates for the demographic subgroups revealed that women were less likely to accept the COVID-19 vaccine Results indicated that, when examining the overall prevalence rate of vaccine acceptance, there was a small but nonsignificant decline in vaccine acceptance over time (b = -.01, p = .484; Table 3 ). We additionally assessed vaccine acceptance for each specific subgroup (in cases where there were at least 5 studies) given that the trajectory of vaccine acceptance rates may have differed as a function of demographic group membership. Results were similar for each subgroup, with the exception of republicans who displayed a significant decrease in vaccine acceptance across time (b = -.03, p = .040) and healthcare professionals who demonstrated decreasing vaccine hesitancy over time (b = .16, p < .001). We also compared vaccine acceptance prevalence rates before and after the vaccine was approved for emergency use and results (Table 1 ) indicated no significant difference. Finally, Figure 4 provides a comparison of study prevalence rates with actual vaccination rates. significantly more likely to decline the COVID-19 vaccine as compared to their counterparts.

Further, the largest odds ratios were observed for race (i.e., for comparisons of Black and White participants) and political affiliation.

When estimated across the 46 included samples and nearly 170,000 Americans, less than two-thirds of eligible adults reported they were willing to accept the COVID-19 vaccine. The proportion willing to receive the vaccine, however, varied substantially across demographic subgroups. Indeed, women, Black and Hispanic Americans, younger adults, people with lower educational attainment, people with lower incomes, people living in rural areas, and Republicans were less inclined to receive the COVID-19 vaccine than their counterparts mirroring national polls from the same time period. 13, 14 This variation across demographic groups helps explain why a third of eligible Americans remain unvaccinated. Moreover, vaccine hesitancy among health care professionals lagged behind most demographic groups.

We also found a small but nonsignificant overall decline in vaccine acceptance across time, with this difference reaching significance among republicans. These findings are consistent with previous survey-based studies which documented a decline in vaccine acceptance during 2020. 15 As the vaccine development timeline became public, some Americans grew concerned about the speed of the testing and approval process and side effects documented in clinical trials.

The lull in COVID-19 cases in the fall or general complacency may also have played a role in changing vaccine attitudes. 16 In contrast to the trend observed across all participants, however, health care professionals demonstrated an increase in vaccine acceptance over time whereas republicans demonstrated a significant decrease.

National polls indicate that, since May 2021, vaccine attitudes have continued to improve, 1 but these improvements are not shared equally across demographic groups. Looking at actual vaccination rates (Figure 4) , we find that while women were substantially less likely than men to report a willingness to vaccinate, more women than men actually received COVID-19 vaccination. Despite the widespread, and at times stereotypical, portrayal of Black Americans as vaccine hesitant, we find that the vaccination rate among Black Americans exceeds initial willingness estimates, suggesting that hesitancy may be declining in this group. Conversely, fewer White Americans received vaccinations as compared to the percentage who reported being willing to accept the vaccine. These data provide additional context for indexing how vaccine acceptance rates have changed over time and suggest that for women, Black Americans, and people over 65, hesitancy appears to be declining while hesitancy remains stable or is potentially increasing among other groups including men, Hispanic Americans, and those under 65.

This meta-analysis primarily addressed two research questions: 1) how many people intended to get the COVID-19 vaccine and 2) what subgroups are more or less willing to receive the vaccine. These questions can inform interventions to improve COVID-19 vaccine uptake by identifying the scope of the problem (i.e., estimating how many people indicate they are vaccine hesitant or would refuse the vaccine), the populations that are most in need of intervention, and the concerns that a potential vaccine campaign should address. Importantly, a sizable portion of Americans remains hesitant to receive COVID-19 vaccination which places strain on the U.S.

health care system and creates disruptions to many social, educational, and economic institutions. 17, 18 Taking the groups with the highest odds of refusing COVID-19 vaccination during the J o u r n a l P r e -p r o o f study period as an example, Americans identifying as Republican or Black, provides evidence that the factors that undergird hesitancy differ between these and other demographic groups.

Studies have demonstrated that key vaccine concerns among Republicans include a lack of trust in government and science 10 as well as exposure to misinformation. 19 Black Americans, by contrast, are more likely to cite a lack of trust in medicine stemming from long-standing mistreatment and exploitation in medical settings. 7, [20] [21] [22] [23] Interventions to improve vaccine uptake, accordingly, should take a tailored approach to address the concerns specific to demographic subgroups, and our findings help illuminate which groups should be prioritized for interventions to reduce vaccine hesitancy. 14 Others that would likely benefit from targeted interventions include young adults and Americans with lower income or educational attainment. Studies suggest that key concerns in these groups relate to misinformation about infertility and misperceptions that the COVID-19 vaccine is not free and that they may be billed later for the appointment. 24 

Funding statement: This study was not financially supported.

Ethical approval: Because this study did not constitute human subjects research, no approval was required from an institutional review board.

Competing interests disclosure: The authors have no conflicts of interest to report. 

Note: k = the number of independent samples; N = sample size; p ̅ = sample size-weighted mean proportion; SE= standard error of the proportion; 95% CI = 95% confidence interval constructed around the mean proportion; Q = estimate of heterogeneity; Younger adults = people aged 18-29; Older adults = people aged 60 and older. 303.70* Note: k = the number of independent samples; N = sample size; OR = sample size-weighted mean odds ratio; SE = standard error of the odds ratio; 95% CI = 95% confidence interval constructed around the mean odds ratio; Q = estimate of heterogeneity; ORlog = log transformed mean sample-weighted odds ratio; SElog = standard error of the log transformed odds ratio; 95% CIlog = 95% confidence interval constructed around the mean log odds ratio; Women = reference group is males; Black and Hispanic = reference group is White, non-Hispanic respondents; Older adults = compares people over 60 to people under 60; Younger adults = compares people 18- Notes: Estimates of the reported prevalence rates were derived from the current meta-analytic estimates of the prevalence of vaccine acceptance across demographic groups in the United States. Estimates of the actual vaccination rates were calculated by dividing the number of people in each demographic group who are fully vaccinated by the total number of people in that demographic group who are eligible to receive the vaccine (i.e., the number of people who are 12 years of age and older). Estimates of the total number of people who have received the vaccine were taken from the Centers for Disease Control and Prevention COVID Data tracker. In cases of missing data (i.e., cases where people did not report their demographic information), we multiplied the total number of cases where demographic information was missing by the proportion of that demographic group in the population to approximate the number of cases that were missing from each demographic subgroup. We then added the estimate of missing data to the total of known vaccination cases. Estimates of the total population over 12 years of age for each demographic group were taken from the U.S. Census Bureau's American Community Survey 2019 population estimates. Because the U.S. Bureau reports information for Americans 65 and older, we used 65 as the cutoff to calculate the actual and intended vaccination rates. This differs from our primary analyses in which 60 and over was used as a cutoff to preserve the maximum number of studies measuring age and vaccine intentions.

KFF COVID-19 Vaccine Monitor

Kaiser Family Foundation Vaccine Monitor

Group on Vaccine Hesitancy. Vaccine hesitancy: Definition, scope and determinants

Identifying and addressing vaccine hesitancy

Types of infectious outbreaks and their impact in elderly care facilities: a review of the literature

Nursing home workers opt out of coronavirus vaccine in Maryland, Virginia, D.C. The Washington Post

A three-tiered approach to address barriers to COVID-19 vaccine delivery in the Black community. The Lancet Global Health

Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America

Socioeconomic status, demographics, beliefs and A(H1N1) vaccine uptake in the United States

Covid-19 vaccine hesitancy among ethnic minority groups

COVID-19 and vaccine hesitancy: A longitudinal study

Comparing meta-analytic moderator estimation techniques under realistic conditions

Development of AMSTAR: a measurement tool to assess the methodological quality of systematic reviews

KFF COVID-19 Vaccine Monitor Dashboard | KFF

Strategies for Building Confidence in the COVID-19 Vaccines. Strategies for Building Confidence in the COVID-19 Vaccines

National Trends in the US Public's Likelihood of Getting a COVID-19 Vaccine

High but slightly declining COVID-19 vaccine acceptance and reasons for vaccine acceptance

How Vaccine Hesitancy Is Driving Breakthrough Infections in Nursing Homes | The New Yorker. The New Yorker

At least 90,000 students have had to quarantine because of COVID-19 so far this school year. The Hill

Donald Trump and vaccination: The effect of political identity, conspiracist ideation and presidential tweets on vaccine hesitancy

Measuring vaccine hesitancy, confidence, trust and flu vaccine uptake: Results of a national survey of White and African American adults

COVID-19 Related Medical Mistrust, Health Impacts, and Potential Vaccine Hesitancy Among Black Americans Living With HIV

Predictors of COVID-19 Vaccine Hesitancy: Socio-demographics, Co-Morbidity and Past Experience of Racial Discrimination. medRxiv

Overcoming Barriers to COVID-19 Vaccination in African Americans: The Need for Cultural Humility

Sources of Vaccine Hesitancy: Pregnancy, Infertility, Minority Concerns, and General Skepticism. Open Forum Infectious Diseases

Nearly 7 million Americans might not get a COVID-19 vaccines because they don't know it's free

Household Pulse Survey. COVID-10 Vaccination Tracker